title: Diabetes: Antibiotics or prodiabetics?
authors.affiliation: Institut des Maladies Métaboliques et Cardiovasculaires, INSERM U1048, 1 Avenue Jean Poulhès, F-31432 Toulouse, France.
authors.forename: Rémy
authors.initials: R
authors.lastname: Burcelin
authors.affiliation: Institut des Maladies Métaboliques et Cardiovasculaires, INSERM U1048, 1 Avenue Jean Poulhès, F-31432 Toulouse, France.
authors.forename: Jacques
authors.initials: J
authors.lastname: Amar
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002511:Cephalosporins / Q000009:adverse effects*; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced*; D057286:Electronic Health Records / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D018942:Macrolides / Q000009:adverse effects*; D008297:Male; D010406:Penicillins / Q000009:adverse effects*; D015363:Quinolones / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D018942:Macrolides; D010406:Penicillins; D015363:Quinolones